Zhou Haijun, Ro Jae Y, Truong Luan D, Ayala Alberto G, Shen Steven S
Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Weill Medical College of Cornell University Houston, TX, USA.
Am J Clin Exp Urol. 2014 Jul 12;2(2):156-60. eCollection 2014.
Intraoperative frozen section (FS) evaluation of ureteral and urethral margins is frequently requested during radical cystoprostatectomy in patients with bladder urothelial carcinoma. However, it is still controversial whether intraoperative FSs of ureteral and urethral margins are necessary in all patients with cystoprostatectomy or a risk-based assessment with limited to the high risk patients is the best approach. A total of 203 radical cystoprostatectomy specimens with FS evaluation on margin status from men treated for bladder urothelial carcinoma from 2003 to 2010 in our institution were reviewed. Clinicopathologic features studied include: patients' age, pathologic tumor stage, presence of carcinoma in- situ (CIS), and intraoperative FS diagnosis. All 203 patients had intraoperative FS evaluation of ureter, and of these, 37 patients had additional urethra FS evaluation. Of the 203 ureteral FS cases, 17 (8.4%) had positive margin for CIS (16 cases) or CIS with invasive urothelial carcinoma (1 case). All 17 patients with positive ureteral margin on FS had concomitant CIS in the bladder (15.5%; 17 of 110 patients). In contrast, none of the patients without concomitant CIS (n=93) had positive ureteral margins on FS. Among 37 patients who also had FS evaluation on urethral resection margin, 3 patients (8.1%) had positive margins for CIS and all three of them had concomitant CIS in the bladder. Positive ureteral/urethral margin was not associated with patients' age or tumor stage, but was significantly associated with the presence of CIS in the bladder (p<0.001). Our study demonstrates that presence of concomitant CIS in bladder cancer was often associated with positive ureteral or urethral margin for CIS or invasive carcinoma; therefore, intraoperative FS evaluation may be indicated to these patients with concomitant bladder CIS. In contrast, in patients with no associated concomitant CIS in the bladder, FS of ureteral/urethral margins may not be necessary unless other clinical justification is present.
在膀胱尿路上皮癌患者的根治性膀胱前列腺切除术中,经常需要对输尿管和尿道切缘进行术中冰冻切片(FS)评估。然而,对于所有接受膀胱前列腺切除术的患者,输尿管和尿道切缘的术中FS是否必要,或者仅限于高危患者的基于风险的评估是否是最佳方法,仍存在争议。我们回顾了2003年至2010年在我们机构接受膀胱尿路上皮癌治疗的男性患者的203份根治性膀胱前列腺切除标本,并对切缘状态进行了FS评估。研究的临床病理特征包括:患者年龄、病理肿瘤分期、原位癌(CIS)的存在以及术中FS诊断。所有203例患者均对输尿管进行了术中FS评估,其中37例患者还对尿道进行了FS评估。在203例输尿管FS病例中,17例(8.4%)切缘CIS阳性(16例)或CIS合并浸润性尿路上皮癌(1例)。所有17例输尿管切缘FS阳性的患者膀胱均伴有CIS(15.5%;110例患者中的17例)。相比之下,没有合并CIS的患者(n = 93)中,没有一例输尿管切缘FS阳性。在37例也对尿道切缘进行FS评估的患者中,3例(8.1%)切缘CIS阳性,且这3例患者膀胱均伴有CIS。输尿管/尿道切缘阳性与患者年龄或肿瘤分期无关,但与膀胱中CIS的存在显著相关(p<0.001)。我们的研究表明,膀胱癌合并CIS通常与输尿管或尿道切缘CIS或浸润性癌阳性相关;因此,对于这些合并膀胱CIS的患者,可能需要进行术中FS评估。相比之下,在膀胱中没有相关合并CIS的患者中,除非有其他临床理由,否则可能不需要对输尿管/尿道切缘进行FS评估。